CLASS I Drug recall · Reported 20 Sep 2017 · FDA Enforcement Report

STEN Z (2, 17a-Dimethyl-17b-hydroxy-5a-androst-1-en recalled

Andropharm is recalling Andropharm Sten Z (2, 17a-Dimethyl-17b-hydroxy-5a-androst-1-en-3-one 10mg and, distributed in Florida. The recall was initiated on 6 Jun 2017 and the FDA has classified it as Class I.

Check your package

Lot, batch or date codesAll lots remaining within expiry.
Quantity recalled150 bottles

Check the lot number on your package against the affected lots. If it matches, contact the pharmacy that dispensed it or your prescriber before stopping any medication.

Recall details

Recall number
D-1142-2017
FDA event ID
77664
Recalling firm
Andropharm, Boca Raton, FL
Classification
Class I
Status
Terminated
Recall initiated
6 Jun 2017
FDA classified
12 Sep 2017
Reported
20 Sep 2017
Type
Voluntary: Firm initiated
Customers notified by
Letter
Reason category
Packaging Defects

Timeline

6 Jun 2017Recall initiated by company
12 Sep 2017Classified by FDA+98 days
20 Sep 2017Published in enforcement report+8 days

Companies usually start a recall weeks before the FDA classifies and publishes it; the gap above is that lag.

Reason for recall

Marketed without an approved NDA/ANDA: product label states it contains anabolic steroids.

Packaging recalls include wrong labels, wrong products in the wrong bottle, missing leaflets, short-filled or empty capsules and seals that fail.

Product as listed by the FDA

ANDROPHARM STEN Z (2, 17a-Dimethyl-17b-hydroxy-5a-androst-1-en-3-one 10mg and 17b-hydroxy-2a, 17b-dimethyl-5a-androstan-3-one azine 10 mg) capsule, packaged in 60-count bottle, Andropharm.com, UPC: 6 42125 50294 8

Where it was distributed

Florida

Florida

Questions about this recall

Is STEN Z (2, 17a-Dimethyl-17b-hydroxy-5a-androst-1-en-3-one 10mg and 17b-hydroxy-2a recalled?

Yes. Andropharm recalled STEN Z (2, 17a-Dimethyl-17b-hydroxy-5a-androst-1-en-3-one 10mg and 17b-hydroxy-2a on 6 Jun 2017. The recall is Class I and its status is Terminated. Recall number D-1142-2017.

Why was it recalled?

Marketed without an approved NDA/ANDA: product label states it contains anabolic steroids.

Which lots are affected?

All lots remaining within expiry.

Where was it sold?

Florida

What should I do if I have it?

Check the lot number on your package against the affected lots. If it matches, contact the pharmacy that dispensed it or your prescriber before stopping any medication.

What does Class I mean?

Class I is the most serious FDA recall category: there is a reasonable probability that using the product will cause serious health consequences or death.

Read the official FDA notice · Source record retrieved 21 Sep 2026. The FDA describes openFDA data as unvalidated; the official notice takes precedence. This page reports the record and gives no medical advice.

More recalls from Andropharm

All 2